Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Heinonen

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Circulation Research|August 22, 2009
Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapyMikko P Turunen, Tiia Lehtola, Suvi E Heinonen, et al.
Neuroscience Letters|July 22, 1998
Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's diseaseT Pirttilä, K Koivisto, P D Mehta, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2011
Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in miceJohanna M U Silvola, Antti Saraste, Sarita Forsback, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 2011
Vascular endothelial growth factor (VEGF)-D stimulates VEGF-A, stanniocalcin-1, and neuropilin-2 and has potent angiogenic effectsSuvi Jauhiainen, Sanna-Kaisa Häkkinen, Pyry I Toivanen, et al.
Chemical Science|July 13, 2018
Analysis of transition state mimicry by tight binding aminothiazoline inhibitors provides insight into catalysis by human <i>O</i>-GlcNAcaseN Cekic, J E Heinonen, K A Stubbs, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 12, 2014
Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesisTaina Vuorio, Harri Nurmi, Karen Moulton, et al.
Cardiovascular Research|July 17, 2010
Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptorsPetri I Mäkinen, Jari P Lappalainen, Suvi E Heinonen, et al.
Journal of Diabetes Research|March 19, 2015
Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approachesSuvi E Heinonen, Guillem Genové, Eva Bengtsson, et al.
Diabetes & Vascular Disease Research|March 4, 2018
In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR<sup>-/-</sup>ApoB<sup>100/100</sup> miceFabiana Blanco, Suvi E Heinonen, Erika Gurzeler, et al.
Cardiovascular Research|June 13, 2013
The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse modelsSuvi E Heinonen, Annukka M Kivelä, Jenni Huusko, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Circulation Research|August 22, 2009
Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapyMikko P Turunen, Tiia Lehtola, Suvi E Heinonen, et al.
Neuroscience Letters|July 22, 1998
Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's diseaseT Pirttilä, K Koivisto, P D Mehta, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2011
Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in miceJohanna M U Silvola, Antti Saraste, Sarita Forsback, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 2011
Vascular endothelial growth factor (VEGF)-D stimulates VEGF-A, stanniocalcin-1, and neuropilin-2 and has potent angiogenic effectsSuvi Jauhiainen, Sanna-Kaisa Häkkinen, Pyry I Toivanen, et al.
Chemical Science|July 13, 2018
Analysis of transition state mimicry by tight binding aminothiazoline inhibitors provides insight into catalysis by human <i>O</i>-GlcNAcaseN Cekic, J E Heinonen, K A Stubbs, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 12, 2014
Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesisTaina Vuorio, Harri Nurmi, Karen Moulton, et al.
Cardiovascular Research|July 17, 2010
Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptorsPetri I Mäkinen, Jari P Lappalainen, Suvi E Heinonen, et al.
Journal of Diabetes Research|March 19, 2015
Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approachesSuvi E Heinonen, Guillem Genové, Eva Bengtsson, et al.
Diabetes & Vascular Disease Research|March 4, 2018
In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR<sup>-/-</sup>ApoB<sup>100/100</sup> miceFabiana Blanco, Suvi E Heinonen, Erika Gurzeler, et al.
Cardiovascular Research|June 13, 2013
The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse modelsSuvi E Heinonen, Annukka M Kivelä, Jenni Huusko, et al.
Pageof 13